New Options in Myelodysplastic Syndromes From ASCO 2022 New Options in Myelodysplastic Syndromes From ASCO 2022

Novel treatment options in lower- and higher-risk patients with myelodysplastic syndromes and a promising targeted therapy are among MDS highlights from ASCO 2022, as discussed by Dr Amy DeZern.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news